IVA_01_337_HNAS_16_002 4 marzo, 2019 / 0 TwittearCompartirCompartir0 CompartirA randomized, double-blind, placebo-controlled, multicenter, dose-range, proof-of-concept, 24-week treatment study of IVA337 in adult subjects with nonalcoholic steatohepatitis (NASH)TwittearCompartirCompartir0 Compartir